ClinicalTrials.Veeva
Menu

Find clinical trials for Multiple Myeloma in San Antonio, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Plasma Cell Cancer
Lymphoma
Hematologic Cancer
Cancer
Leukemia
Smoldering Multiple Myeloma
Non-Hodgkin Lymphoma

Multiple Myeloma trials near San Antonio, TX, USA:

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

lenalidomide, and dexamethasone (DRd) for first-line treatment of multiple myeloma (MM).FDA has approved selinexor plus dexamethaso ...

Enrolling
Plasma Cell Myeloma
Myeloma, Plasma Cell
Drug: Selinexor
Drug: Daratumumab

Phase 2

US Oncology Network
US Oncology Network

San Antonio, Texas, United States and 9 other locations

This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients...

Enrolling
Multiple Myeloma
Drug: Teclistamab
Drug: Talquetamab

Phase 2

SCRI Development Innovations

San Antonio, Texas, United States and 11 other locations

progression-free survival (PFS) in participants with newly diagnosed multiple myeloma (a blood cancer of plasma cells) who are not ...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab SC
Drug: Daratumumab IV

Phase 3

Janssen (J&J Innovative Medicine)
Janssen (J&J Innovative Medicine)

San Antonio, Texas, United States and 211 other locations

doses) of the study medicine (elranatamab) in participants with multiple myeloma that has come back after responding to treatment o ...

Active, not recruiting
Multiple Myeloma
Drug: Elranatamab

Phase 2

Pfizer
Pfizer

San Antonio, Texas, United States and 41 other locations

The purpose of this study is to evaluate the effectiveness and safety of BMS-986393 in participants with relapsed or refractory multiple myeloma...

Enrolling
Multiple Myeloma
Biological: BMS-986393

Phase 2

Juno Therapeutics

San Antonio, Texas, United States and 41 other locations

B-cell maturation antigen (BCMA) is a target present on tumor cells in participants with multiple myeloma. Belantamab mafodotin (GS...

Enrolling
Multiple Myeloma
Drug: Belantamab mafodotin
Drug: GSK3174998

Phase 1, Phase 2

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

San Antonio, Texas, United States and 58 other locations

Phase 1 study comprised of open-label, dose escalation, multiple cohorts of P-BCMA-ALLO1 allogeneic T stem cell memory (Tscm) CAR-T cells in ...

Enrolling
Multiple Myeloma
Biological: P-BCMA-ALLO1 CAR-T cells
Drug: Rimiducid

Phase 1

Poseida Therapeutics

San Antonio, Texas, United States and 14 other locations

and dexamethasone (PVd) in participants with relapsed or refractory multiple myeloma (RRMM) who received between 1 to 3 prior lines...

Enrolling
Relapsed or Refractory Multiple Myeloma
Drug: Pomalidomide
Drug: mezigdomide

Phase 3

Celgene
Celgene

San Antonio, Texas, United States and 233 other locations

This study will evaluate the efficacy, safety, and pharmacokinetics of cevostamab in participants with relapsed or refractory multiple myeloma...

Enrolling
Multiple Myeloma
Drug: Cevostamab
Drug: Tocilizumab

Phase 1, Phase 2

Roche
Roche

San Antonio, Texas, United States and 33 other locations

with or without Nirogacestat in adults with relapsed or refractory multiple myeloma after a lymphodepletion regimen of ALLO-647 in ...

Active, not recruiting
Relapsed/Refractory Multiple Myeloma
Drug: Fludarabine
Biological: ALLO-647

Phase 1

Allogene Therapeutics

San Antonio, Texas, United States and 10 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems